Q1 2016 Holdings
Filed 2016-05-16 | 47 holdings | $105.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $39.4M | 478,287 | 37.3% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $25.1M | 1,332,520 | 23.7% |
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $22.7M | 1,428,931 | 21.4% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $9.4M | 729,699 | 8.9% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $8.3M | 109,806 | 7.9% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $90.6K | 10,718,420 | 0.1% |
| Medivation Inc | COM | 58501N101 | $82.1K | 1,786,599 | 0.1% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $59.5K | 3,099,336 | 0.1% |
| Penumbra Inc(PEN) | COM | 70975L107 | $58.3K | 1,267,967 | 0.1% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $56.5K | 19,150,650 | 0.1% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $47.3K | 4,320,192 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $43.3K | 2,275,765 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $34.0K | 970,121 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $33.8K | 1,053,018 | 0.0% |
| Allergan PLC | SHS | G0177J108 | $30.7K | 114,448 | 0.0% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $29.4K | 1,056,059 | 0.0% |
| Centene Corp del(CNC) | COM | 15135B101 | $29.0K | 470,549 | 0.0% |
| Nanostring Technologies Inc(NSTGEUR) | COM | 63009R109 | $28.4K | 1,863,035 | 0.0% |
| Aetna Inc New | COM | 00817Y108 | $21.5K | 191,625 | 0.0% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $21.2K | 329,013 | 0.0% |
| Endologix Inc | COM | 29266S106 | $20.6K | 2,468,847 | 0.0% |
| Model N Inc(MODNEUR) | COM | 607525102 | $20.3K | 1,885,359 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $18.1K | 889,607 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $17.0K | 1,238,273 | 0.0% |
| Neuroderm LTD | ORD SHS | M74231107 | $16.7K | 1,180,887 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $15.7K | 216,594 | 0.0% |
| VCA Inc | COM | 918194101 | $12.0K | 207,800 | 0.0% |
| Clovis Oncology IncCall | CALL | 189464900 | $11.5K | 600,000 | 0.0% |
| Oxford Immunotec Global PLC | ORD SHS | G6855A103 | $8.7K | 876,088 | 0.0% |
| Conformis Inc(CFMS) | COM | 20717E101 | $8.5K | 792,355 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $7.3K | 130,571 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $6.8K | 660,129 | 0.0% |
| Heartware Intl Inc | COM | 422368100 | $6.7K | 214,771 | 0.0% |
| Press Ganey Hldgs Inc | COM | 74113L102 | $6.6K | 218,214 | 0.0% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $5.9K | 82,300 | 0.0% |
| Ehealth Inc(EHTH) | COM | 28238P109 | $4.0K | 421,742 | 0.0% |
| Pfizer Inc(PFE) | COM | 717081103 | $3.7K | 123,800 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $3.5K | 263,000 | 0.0% |
| Array Biopharma Inc | NOTE 3.000% 6/0 | 04269XAA3 | $3.2K | $4,000,000 | 0.0% |
| Durect Corp(DRRXEUR) | COM | 266605104 | $3.1K | 2,327,137 | 0.0% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $2.7K | 552,713 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $2.7K | 1,486,980 | 0.0% |
| Ishares TR(IHF) | US HLTHCR PR ETF | 464288828 | $551 | 4,520 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $488 | 27,055 | 0.0% |
| Axovant Sciences LTD | COM | G0750W104 | $115 | 10,000 | 0.0% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $58 | 19,710 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $25 | 10,000 | 0.0% |